Inflammation in atherosclerosis: pathophysiology and mechanisms

A Ajoolabady, D Pratico, L Lin, CS Mantzoros… - Cell death & …, 2024 - nature.com
Atherosclerosis imposes a heavy burden on cardiovascular health due to its indispensable
role in the pathogenesis of cardiovascular disease (CVD) such as coronary artery disease …

NPM1‐mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions

B Falini - American journal of hematology, 2023 - Wiley Online Library
The nucleophosmin (NPM1) gene encodes for a multifunctional chaperone protein that is
localized in the nucleolus but continuously shuttles between the nucleus and cytoplasm …

[HTML][HTML] Acute myeloid leukemia

A Vakiti, SB Reynolds, P Mewawalla - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Acute Myeloid Leukemia - StatPearls - NCBI Bookshelf US flag An official website of the United
States government Here's how you know NIH NLM Logo Access keys NCBI Homepage …

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1

W Fiskus, CP Mill, C Birdwell, JA Davis, K Das… - Blood cancer …, 2023 - nature.com
Monotherapy with Menin inhibitor (MI), eg, SNDX-5613, induces clinical remissions in
patients with relapsed/refractory AML harboring MLL1-r or mtNPM1, but most patients either …

NPM 1 Mutations in AML—The Landscape in 2023

N Sharma, JL Liesveld - Cancers, 2023 - mdpi.com
Simple Summary The nucleophosmin 1 (NPM1) gene is mutated in approximately one-third
of newly diagnosed acute myeloid leukemia (AML) cases. NPM1mutated AML (NPM1 mut …

Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia

DJ Chandra, CA Lachowiez, S Loghavi - Blood Reviews, 2024 - Elsevier
The updated WHO 5th edition and ICC 2022 classification systems for AML aim to refine our
diagnostic criteria and definitions of AML with deeper incorporation of cytogenetic and …

Biomarkers as targets for CAR-T/NK cell therapy in AML

R Shao, Z Li, H **n, S Jiang, Y Zhu, J Liu, R Huang… - Biomarker …, 2023 - Springer
The most common kind of acute leukemia in adults is acute myeloid leukemia (AML), which
is often treated with induction chemotherapy regimens followed by consolidation or …

Molecular landscape and validation of new genomic classification in 2668 adult AML patients: real life data from the PETHEMA registry

C Sargas, R Ayala, MJ Larráyoz, MC Chillón… - Cancers, 2023 - mdpi.com
Simple Summary Next–Generation Sequencing (NGS) has provided a deeper genetic
understanding of acute myeloid leukemia (AML) that has been recently incorporated into …

Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation

L Chin, CYG Wong, H Gill - International Journal of Molecular Sciences, 2023 - mdpi.com
Mutations in NPM1, also known as nucleophosmin-1, B23, NO38, or numatrin, are seen in
approximately one-third of patients with acute myeloid leukaemia (AML). A plethora of …

Therapeutic targeting of the menin–KMT2A interaction

PR Freire, JA Cutler… - Annual Review of Cancer …, 2024 - annualreviews.org
The direct targeting of chromatin-associated proteins is increasingly recognized as a
potential therapeutic strategy for the treatment of cancer. In this review, we discuss a …